Loading clinical trials...
Loading clinical trials...
Evaluation of the Prevalence of Faecal Bacteriophage Carriage in Patients With Digestive Symptoms.
Define the prevalence of fecal phage carriage in individuals with digestive symptoms (i) Determine the concentrations of infectious fecal phages in the stools of individuals with digestive symptoms (detection by culture) (ii) Determine fecal phage genome concentrations in the stools of individuals with digestive symptoms (PCR detection) (iii) Explore factors that could impact fecal phage carriage (patients with digestive symptoms vs. healthy individuals, immunocompromised patients vs. immunocompetent patients)
Age
18 - 60 years
Sex
ALL
Healthy Volunteers
No
CHRU Nancy
Nancy, France
Start Date
November 15, 2024
Primary Completion Date
November 15, 2024
Completion Date
November 15, 2025
Last Updated
July 30, 2024
300
ESTIMATED participants
bacteriophage detection
OTHER
Lead Sponsor
Central Hospital, Nancy, France
NCT05199532
NCT06579170
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions